Metraipolis › archive › dc_71c6ebd08d0e

T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer models — Europe PMC PMID:41528883

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41528883
DOI
10.1172/jci196613
License (as archived)
solo-consultazione
Archived
2026-11-06T20:39:42.086Z
SHA-256 of the archived text
90388d33f19dac2af29380750ee9ce68cbd39be0b4b2486cfac4b0db77507375
Stable URL of this page
https://metraipolis.com/documento/dc_71c6ebd08d0e

How to cite

T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer models — Europe PMC PMID:41528883 — Europe PMC (en), https://europepmc.org/article/MED/41528883 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_71c6ebd08d0e (Metraipolis archive dc_71c6ebd08d0e, sha256 90388d33f19dac2af29380750ee9ce68cbd39be0b4b2486cfac4b0db77507375)
BibTeX
@misc{dc71c6ebd08d0e,
  title = {T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer models — Europe PMC PMID:41528883},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41528883},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_71c6ebd08d0e; sha256 90388d33f19dac2af29380750ee9ce68cbd39be0b4b2486cfac4b0db77507375},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41528883. Agents can read the archived copy with the MCP tool read_document.